europd_logo

At the 13th European Peritoneal Dialysis Meeting held in Dublin over the last few days, a poster on the development, validation and CE-certification of PERiPLEX by Barbara Fallowfield, Commercial Manager at Mologic, was shown via the meeting electronic portal.

The poster generated a lot of interest in PERiPLEX among conference attendees, who recognised that the availability of the test could make a big difference to patients’ lives.

PERiPLEX is an infection test for peritoneal dialysis users, which has been developed by Mologic Scientists and recently gained CE-Mark approval.

The availability of this simple to use test will make a big difference to patients’ lives.

To download a copy of our PERiPLEX poster, click the images or link below:

PeriPlexPoster20171003

For more details about our PERiPLEX test, click the images or link below:

PeriPlexIFU

PeriPlexInfoPage
https://mologic.co.uk/periplex

Mologic is a leading developer of lateral flow and rapid diagnostic technologies, products and services. We work with companies, researchers and clinicians to help them deliver fast, reliable and accurate diagnosis at the point-of-care.

Our Co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test. Launched in 1988, it was the world’s first commercial application of lateral flow technology. The creativity, insight and knowledge that led to that ground-breaking invention has guided Mologic since our formation in 2003.